NEW YORK, January 6, 2017 /PRNewswire/ --
Stock-Callers.com puts focus on the Specialty Chemicals industry to see how some equities have fared over the last few trading sessions. Companies in today's lineup are: Amyris Inc. (NASDAQ: AMRS), LyondellBasell Industries N.V. (NYSE: LYB), Platform Specialty Products Corp. (NYSE: PAH), and Olin Corp. (NYSE: OLN). Specialty chemicals are chemical products that are sold on the basis of their performance or function, rather than their composition. They can be single-chemical entities or formulations whose composition sharply influences the performance and processing of the customer's product. Learn more about these stocks by downloading their free research reports in PDF format at:
On Thursday, shares in Emeryville, California headquartered Amyris Inc. recorded a trading volume of 2.06 million shares. The stock ended at $0.79, rising 1.51% from the last trading session. The Company's shares have gained 34.20% over the previous three months and 8.47% on an YTD basis. The stock is trading above its 200-day moving average by 16.56%. Furthermore, shares of Amyris, which provides various alternatives to a range of petroleum-sourced products worldwide, have a Relative Strength Index (RSI) of 55.29.
On January 05th, 2017, Amyris announced the appointment of Kathleen Valiasek, a senior finance and business executive with over 20 years experience serving start-up, venture-backed and Fortune 500 companies as Chief Financial Officer effective immediately. She replaces Raffi Asadorian, who has resigned to pursue a new opportunity, but will continue to support specific projects, as well as serve in an ad hoc consulting capacity to ensure a smooth transition. Sign up and read the free research report on AMRS at:
London, UK-based LyondellBasell Industries N.V.'s stock finished yesterday's session 0.12% lower at $88.68 with a total trading volume of 2.30 million shares. The Company's shares have gained 0.09% in the last one month, 10.12% over the previous three months, and 3.38% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 4.83% and 10.05%, respectively. Furthermore, shares of LyondellBasell Industries, which operates as a manufacturer of chemicals and polymers, refiner of crude oil, producer of gasoline blending components, and developer and licensor of technologies for production of polymers, have an RSI of 59.95.
On December 29th, 2016, research firm Cowen reiterated its 'Market Perform' rating on the Company's stock with an increase of the target price from $87 a share to $90 a share.
As per a SEC filing dated December 13th, 2016, LyondellBasell Industries appointed Michael Sumruld as its Chief Accounting Officer on December 07th, 2016, effective as of January 03rd, 2017. Mr. Sumruld, age 46, most recently worked for Baker Hughes Incorporated. Mr. Sumruld is a certified public accountant and holds a bachelor's degree in accounting from the University of Houston and an MBA from Texas A&M University. The complimentary research report on LYB can be downloaded at:
Platform Specialty Products
At the closing bell on Thursday, shares in West Palm Beach, Florida headquartered Platform Specialty Products Corp. climbed 1.77%, ending the day at $10.34. The stock recorded a trading volume of 2.02 million shares. The Company's shares have advanced 9.42% in the last one month, 36.77% over the previous three months, and 5.40% since the start of this year. The stock is trading 15.58% above its 50-day moving average and 15.77% above its 200-day moving average. Moreover, shares of Platform Specialty Products, which produces and sells specialty chemical products in the Americas, the Asia-Pacific, and Europe, have an RSI of 72.37.
On December 07th, 2016, Platform Specialty Products announced that it successfully completed the repricing of $1.3 billion of term loans under its credit agreement. This repricing follows Platform's successful repricing, extension and amendment of $1.95 billion of term loans in October 2016. By incurring a new $610 million USD B-5 term loan tranche and a new €700 million EUR C-4 term loan tranche, Platform refinanced its existing USD B-3 and EUR C-2 term loan tranches, which were not subject to the October repricing and extension. Register for free on Stock-Callers.com and access the latest report on PAH at:
Clayton, Missouri headquartered Olin Corp.'s stock ended the day 1.42% lower at $26.43 with a total trading volume of 1.42 million shares. The Company's shares have gained 29.20% over the previous three months and 3.20% on an YTD basis. The stock is trading 7.12% above its 50-day moving average and 21.05% above its 200-day moving average. Additionally, shares of Olin, which manufactures and distributes chemical products in the US and internationally, have an RSI of 61.60.
As per a SEC filing dated December 19th, 2016, George H. Pain, Senior Vice President, General Counsel, and Secretary of Olin, announced on December 15th, 2016, his intention to retire from Olin effective March 01st, 2017. Get free access to your research report on OLN at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA